Design Principles for Life
, which is responsible for cardiac myocyte contraction, is critical for normal heart function. Numerous proteins in the lumen and membrane of the sarcoplasmic recitulum (SR) are responsible for regulating the cycling of contractile Ca 2ϩ between the SR and the cytosol. An imbalance in the levels of these proteins can impair contractility, leading to cardiac insufficiency and pathology. However, little is known about these processes. In his review (2), Glembotski summarizes studies that address the location and mechanism in cardiac myocytes of the synthesis of secreted and membrane proteins, a subset of which includes contractile Ca 2ϩ -handling proteins. Moreover, the review explores the possibility that protein synthesis and cardiac contractile Ca 2ϩ handling in the SR may be functionally integrated and that this integration may contribute to healthy heart function. Cystic fibrosis (CF) is one of the most common chronic lung diseases in children and young adults and leads to multiorgan dysfunction and premature death. CF is a genetic disease that results from the malfunction of the CF transmembrane conductance regulator (CFTR), a chloride channel that plays a critical role in maintaining water and salt homeostasis across many epithelium-lining tissues. In their review (3), Jih and Hwang examine the gating defects that cause CF. Opening of the CFTR channel is associated with ATP-induced dimerization of its two nucleotide binding domains (NBD1 and NBD2), whereas gate closure is facilitated by ATP hydrolysis-triggered partial separation of the NBDs. This generally held theme of CFTR gating-a strict coupling between the ATP hydrolysis cycle and the gating cycle-is put to the test by recent reports that lead to a new model, featuring energetic coupling between CFTR's NBDs and its two transmembrane domains (TMDs) that form the substrate translocation pathway. Since many pathogenic mutations of CFTR cause gating defects, understanding the molecular mechanism of gating conformational changes should help in the design of novel strategies for the treatment of patients with CF.
RNA editing is a process used by all true metazoans to systematically change genetic information. For example, codons within a mRNA can be recoded, resulting in novel protein isoforms. In their review (1), Garrett and Rosenthal suggest that RNA editing is used to help poikilotherms adapt to cold temperatures. Although much previous research has shown that RNA editing diversifies an organism's transcriptome, the idea that it is used for a specific purpose like temperature adaptation is novel. Although homeotherms, humans, and other organisms that possess stable body temperatures do not use RNA editing as a mechanism for cold adaptation, it could have important implications if used as a directed mechanism for plasticity. For example, a small but growing body of data suggests that RNA editing can change in response to external inputs such as environmental and even social factors. Learning to control the editing process may lead to therapeutic potential by correcting genetic mutations and selectively tuning protein function. Ⅲ
